Sean Rooney, PhD
Dobbs Ferry,NY
Summary
- Recognized industry leader in medical strategy who utilizes wide-ranging therapeutic expertise and exceptional client skills to drive high-impact medical communication initiatives.
- Empathetic and authentic culture builder who believes that great work comes from focusing on your people rather than managing your employees.
- Former managing partner of large Medical Education agency with 100+ employees and >25M in revenue.
- Strategic lead for >100 pitches/tactical presentations, ranging from blockbuster drugs (>25B in revenue) with big pharma to small biotech companies with single products.
- Responsible for the management and development of large medical teams, across both US and EU.
- Broad therapeutic expertise including oncology, autoimmune/inflammatory disease, respiratory, dermatology, gastroenterology, ophthalmology, metabolic disease, rare disease, and more.
- US and global experience working across all aspects of healthcare advertising, including medical affairs, medical education, payor/access, HCP promotion, and DTC, and all steps in product lifecycle, from pre-launch market prep to product launch and maintenance of mature brands.
Overview
13
13
years of professional experience
Work History
Global Chief Science Officer
VML/VMLY&R [A WPP company]
01.2021 - 05.2024
- Led global medical team of >100 individuals, across aspects of healthcare advertising
- Served as medical strategy lead for 10+ successful new business pitches
- Oversaw the integration of multiple unique scientific teams following merger of several individual agencies
- Provided thought leadership pieces delivered to both current and potential clients
- Developed curriculum for Oncology Academy, a training course available to all WPP employees.
Managing Partner
The Sciemonics Group [An Omnicom Company]
11.2019 - 05.2021
- Responsible for defining and leading agency strategy, growth, culture and employee development
- Managed a P&L over >$25M
- Established and implemented business procedures and process improvements.
- Mentored junior staff members, resulting in a more cohesive team and increased overall performance.
- Developed comprehensive business plans that led to significant revenue growth and expansion opportunities.
- Optimized resource allocation, reducing operational costs while maintaining service quality standards.
Dean, Oncology University
Omnicom Health Group
10.2018 - 05.2021
- Led a Omnicom Heath Group (OHG) initiative to train internal staff and selected clients on the basics of oncology.
- Responsibilities included serving as moderator for a two day live event, overseeing curriculum development, and liaising with external KOL presenters.
EVP, Scientific and New Business Strategy
The Scienomics Group
12.2016 - 11.2019
- Responsible for the acquisition of new business as well as the expansion of existing work
- 2018 win rate >60%, including a doubling of oncology associated revenue .
- Enhanced overall business performance by identifying and addressing strategic gaps in the organization.
- Established relationships with client stakeholders, supporting rapid account growth and sustainable development.
VP/SVP, Head of Medical and Scientific Services
The Scienomics Group
01.2011 - 11.2016
- Hired and managed employees to maximize productivity while training staff on best practices and protocols
- Grew team from 5 to 25 members during tenure, with yearly employee retention rate >90%.
- Oversaw the launch of 8 products, as well as 10+ soft launches of additional indications.
- Worked with both US and global teams, as well as both promo and medical affairs disciplines.
- Developed and executed targeted business development initiatives, leading to an expansion of the company''s client base.
Education
Jane Coffin Child Postdoctoral Fellow - Tumor Biology
Rockefeller University
New York, NY08.2008
Ph.D. - Immunology
Harvard University
Boston, MA08.2003
Bachelor of Science - Biology
Villanova University
Villanova, PA12.1992
Skills
- Medical Strategy
- Scientific Communication
- Data Analysis Expertise
- Pre-Launch/Launch
- Medical Affairs
- Medical Education
- Marketing
- KOL Engagement
- Tactical Planning
- New Business
- Team Leadership
- Thought Leadership
Therapeutic Expertise
- Oncology
- Immunology
- Autoimmune/Inflammatory Disease
- Rare Disease
- Dermatology
- Gastroenterology
- Rheumatology
- Respiratory/Pulmonology
- Metabolic Disease
- Ophthalmology
- Vaccines
Publications
- Wu P, van Overbeek M, Rooney S, de Lange T. Apollo contributes to G overhang maintenance and protects leading-end telomeres. Mol Cell. 2010 Aug 27;39(4):606-17
- Mostoslavsky G., Fabian AJ, Rooney S, Alt FW, Mulligan RC. Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16406-11.
- Rooney S, Alt FW, Sekiguchi J, Manis JP. Artemis-independent functions of DNA-dependent protein kinase in Ig heavy chain class switch recombination and development. Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2471-5.
- Rooney S, Chaudhuri J, Alt FW. The role of the non-homologous end-joining pathway in lymphocyte development. Immunol Rev. 2004 Aug;2000:115-31.
- Rooney S, Sekiguchi J, Whitlow S, Eckersdoff M, Manis JP, Lee C, Ferguson DO, Alt FW. Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells. Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2410-5.
- Rooney S, Alt FW, Lombard D, Whitlow S, Eckersdorff M. Fleming J, Furgmann S, Ferguson DO, Schatz DG, Sekiguchi J. Defective DNA repair and increased genomic instability in Artemis-deficient murine cells. J Exp Med. 2003 Mar 3;197(5):553-65.
- Rooney S, Sekiguchi J, Zhu C, Cheng HL, Manis J, Whitlow S, DeVido J, Foy D, Chaudhuri J, Lombard D, Alt FW. Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Mol Cell. 2002 Dec;10(6):1379-90.
- Nelson D, Rooney S, Miller NJ, Mather TN. Complement-mediated killing of Borrelia burgdorferi by nonimmune sera from sika deer. J Parasitol. 2000 Dec;86(6):1232-8.
Timeline
Global Chief Science Officer
VML/VMLY&R [A WPP company]
01.2021 - 05.2024
Managing Partner
The Sciemonics Group [An Omnicom Company]
11.2019 - 05.2021
Dean, Oncology University
Omnicom Health Group
10.2018 - 05.2021
EVP, Scientific and New Business Strategy
The Scienomics Group
12.2016 - 11.2019
VP/SVP, Head of Medical and Scientific Services
The Scienomics Group
01.2011 - 11.2016
Jane Coffin Child Postdoctoral Fellow - Tumor Biology
Rockefeller University
Ph.D. - Immunology
Harvard University
Bachelor of Science - Biology
Villanova University
Similar Profiles
Kabir RoyKabir Roy
REGIONAL DIRECTOR - CUSTOMER EXPERIENCE at VML (A WPP COMPANY)REGIONAL DIRECTOR - CUSTOMER EXPERIENCE at VML (A WPP COMPANY)
Neha VermaNeha Verma
Group Head - Client Success at VMLY&R (StudioX x WPP)Group Head - Client Success at VMLY&R (StudioX x WPP)
Reed WalkerReed Walker
Analytics Manager, Measurement & Optimization at WPP (Wunderman Thompson | VML)Analytics Manager, Measurement & Optimization at WPP (Wunderman Thompson | VML)
Georgette HellerGeorgette Heller
SENIOR DIRECTOR at TRANZACTSENIOR DIRECTOR at TRANZACT
TIMOTHY SOAVETIMOTHY SOAVE
Field Safety Auditor at NYC DDCField Safety Auditor at NYC DDC